IL90499A - Pharmaceutical preparations containing analog (2, (5-oligoadnyl) - Google Patents
Pharmaceutical preparations containing analog (2, (5-oligoadnyl)Info
- Publication number
- IL90499A IL90499A IL9049989A IL9049989A IL90499A IL 90499 A IL90499 A IL 90499A IL 9049989 A IL9049989 A IL 9049989A IL 9049989 A IL9049989 A IL 9049989A IL 90499 A IL90499 A IL 90499A
- Authority
- IL
- Israel
- Prior art keywords
- adenylyl
- compound
- composition according
- deoxyadenylyl
- deoxyadenosine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/712—Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL10670989A IL106709A (en) | 1988-06-09 | 1989-06-01 | Antiviral preparations containing viruses containing 2,5-oligoadnylates |
IL106709A IL106709A0 (en) | 1988-06-09 | 1993-08-16 | Therapeutic uses of 2',5'-oligoadenylates |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20465988A | 1988-06-09 | 1988-06-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL90499A0 IL90499A0 (en) | 1990-01-18 |
IL90499A true IL90499A (en) | 1994-05-30 |
Family
ID=22758878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9049989A IL90499A (en) | 1988-06-09 | 1989-06-01 | Pharmaceutical preparations containing analog (2, (5-oligoadnyl) |
Country Status (14)
Country | Link |
---|---|
EP (2) | EP0420872B1 (zh) |
JP (1) | JP2947580B2 (zh) |
KR (1) | KR0141684B1 (zh) |
CN (1) | CN1107508C (zh) |
AT (2) | ATE141796T1 (zh) |
AU (1) | AU637975B2 (zh) |
CA (1) | CA1335356C (zh) |
DE (2) | DE68927055T2 (zh) |
DK (1) | DK174025B1 (zh) |
ES (1) | ES2016464A6 (zh) |
IL (1) | IL90499A (zh) |
NZ (1) | NZ229422A (zh) |
PT (1) | PT90816B (zh) |
WO (1) | WO1989012380A2 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5550111A (en) * | 1984-07-11 | 1996-08-27 | Temple University-Of The Commonwealth System Of Higher Education | Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof |
IE882585L (en) * | 1988-08-25 | 1990-02-25 | Prendergast Patrick T | Viral treatment system |
PH30703A (en) * | 1990-06-21 | 1997-09-16 | Patrick T Prendergast | Administering particular compounds against variousparasites, mycoplasmas, other indications and otheer indications and other infections. |
US5594121A (en) * | 1991-11-07 | 1997-01-14 | Gilead Sciences, Inc. | Enhanced triple-helix and double-helix formation with oligomers containing modified purines |
AU6632094A (en) * | 1993-04-19 | 1994-11-08 | Gilead Sciences, Inc. | Enhanced triple-helix and double-helix formation with oligomers containing modified purines |
WO1998056385A1 (en) | 1997-06-12 | 1998-12-17 | Temple University - Of The Commonwealth System Of Higher Education | Base-modified derivatives of 2',5'-oligoadenylate and antiviral uses thereof |
US6362171B1 (en) | 1997-06-12 | 2002-03-26 | Temple University-Of The Commonwealth System Of Higher Education | Aminoaklanoyl-linked conjugates of 2′,5′-oligoadenylate and antiviral uses thereof |
AU5429000A (en) * | 1999-06-25 | 2001-01-31 | Sankyo Company Limited | Novel bicyclonucleoside derivatives |
TWI347948B (en) * | 2002-11-19 | 2011-09-01 | Sankyo Co | Novel 2',5'-oligoadenylic acid compositions |
GB201019043D0 (en) | 2010-11-10 | 2010-12-22 | Protea Biopharma N V | Use of 2',5'-oligoadenylate derivative compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4210746A (en) * | 1978-08-10 | 1980-07-01 | National Research Development Corporation | Nucleotide inhibitor of protein synthesis |
US4464359A (en) * | 1981-04-10 | 1984-08-07 | Research Corporation | (2'-5')-Oligo (3'-deoxyadenylate) and derivatives thereof |
US4539313A (en) | 1981-04-10 | 1985-09-03 | Research Corporation | (2'-5')-Oligo (3'-deoxyandenylate) and derivatives thereof |
US4824941A (en) * | 1983-03-10 | 1989-04-25 | Julian Gordon | Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems |
US4859768A (en) * | 1984-07-11 | 1989-08-22 | Temple University Of The Commonwealth System Of Higher Education | Derivatives of 2', 5'-oligoadenylate and antiviral uses thereof |
US4654326A (en) * | 1984-07-12 | 1987-03-31 | Yair Devash | Inhibition of plant viruses with oligonucleotides |
-
1989
- 1989-05-24 AU AU37403/89A patent/AU637975B2/en not_active Ceased
- 1989-05-24 WO PCT/US1989/002284 patent/WO1989012380A2/en active IP Right Grant
- 1989-05-24 DE DE68927055T patent/DE68927055T2/de not_active Expired - Fee Related
- 1989-05-24 KR KR1019900700257A patent/KR0141684B1/ko not_active IP Right Cessation
- 1989-05-24 AT AT89906575T patent/ATE141796T1/de not_active IP Right Cessation
- 1989-05-24 EP EP89906575A patent/EP0420872B1/en not_active Expired - Lifetime
- 1989-05-24 EP EP96101815A patent/EP0716856B1/en not_active Expired - Lifetime
- 1989-05-24 JP JP1506395A patent/JP2947580B2/ja not_active Expired - Fee Related
- 1989-05-24 DE DE68929321T patent/DE68929321T2/de not_active Expired - Fee Related
- 1989-05-24 AT AT96101815T patent/ATE204752T1/de not_active IP Right Cessation
- 1989-06-01 IL IL9049989A patent/IL90499A/en not_active IP Right Cessation
- 1989-06-08 ES ES8901996A patent/ES2016464A6/es not_active Expired - Lifetime
- 1989-06-09 CA CA000602302A patent/CA1335356C/en not_active Expired - Fee Related
- 1989-06-09 CN CN89106235A patent/CN1107508C/zh not_active Expired - Fee Related
- 1989-06-09 PT PT90816A patent/PT90816B/pt not_active IP Right Cessation
- 1989-10-06 NZ NZ229422A patent/NZ229422A/xx unknown
-
1990
- 1990-12-07 DK DK199002913A patent/DK174025B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR0141684B1 (ko) | 1998-06-01 |
AU637975B2 (en) | 1993-06-17 |
CA1335356C (en) | 1995-04-25 |
DE68927055T2 (de) | 1997-04-10 |
EP0716856A3 (en) | 1996-10-30 |
EP0420872B1 (en) | 1996-08-28 |
KR900701279A (ko) | 1990-12-01 |
DK291390D0 (da) | 1990-12-07 |
IL90499A0 (en) | 1990-01-18 |
JP2947580B2 (ja) | 1999-09-13 |
JPH03504970A (ja) | 1991-10-31 |
DK291390A (da) | 1990-12-07 |
ATE141796T1 (de) | 1996-09-15 |
EP0716856A2 (en) | 1996-06-19 |
EP0420872A4 (en) | 1992-10-21 |
DK174025B1 (da) | 2002-04-29 |
WO1989012380A3 (en) | 1990-06-28 |
DE68929321T2 (de) | 2002-05-08 |
DE68927055D1 (de) | 1996-10-02 |
EP0716856B1 (en) | 2001-08-29 |
ES2016464A6 (es) | 1990-11-01 |
WO1989012380A2 (en) | 1989-12-28 |
PT90816A (pt) | 1989-12-29 |
DE68929321D1 (de) | 2001-10-04 |
CN1107508C (zh) | 2003-05-07 |
CN1040321A (zh) | 1990-03-14 |
ATE204752T1 (de) | 2001-09-15 |
PT90816B (pt) | 1994-11-30 |
AU3740389A (en) | 1990-01-12 |
NZ229422A (en) | 1992-12-23 |
EP0420872A1 (en) | 1991-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5550111A (en) | Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof | |
US5643889A (en) | Cholesterol conjugates of 2'5'-oligoadenylate derivatives and antiviral uses thereof | |
EP0694559B1 (en) | 2',5'-Phosphorothioate oligoadenylates and antiviral uses thereof | |
US5700785A (en) | 3'-deoxy or 3'-O-substituted-2',5'-oligoadenylates as antiviral agents | |
CA1335356C (en) | Therapeutic uses of 2',5'-oligoadenylates | |
WO1998056385A1 (en) | Base-modified derivatives of 2',5'-oligoadenylate and antiviral uses thereof | |
EP0777485B1 (en) | 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof | |
EP0630249B1 (en) | Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof | |
IL106709A (en) | Antiviral preparations containing viruses containing 2,5-oligoadnylates | |
NZ240169A (en) | The use of 2',5'-olioadenylates to treat virus infections | |
IE83348B1 (en) | Therapeutic uses of 2',5'-oligoadenylate derivatives | |
WO1998056384A1 (en) | Aminoaklanoyl-linked conjugates of 2',5'-oligoadenylate and antiviral uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
RH1 | Patent not in force |